You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 14, 2025

Details for Patent: 11,324,741


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,324,741 protect, and when does it expire?

Patent 11,324,741 protects CONTRAVE and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 11,324,741
Title:Methods for treating visceral fat conditions
Abstract: Disclosed are methods and compositions for treating visceral fat conditions and/or metabolic syndrome using combinations of naltrexone and bupropion.
Inventor(s): Tollefson; Gary D. (Indianapolis, IN)
Assignee: Nalpropion Pharmaceuticals LLC (Morristown, NJ)
Application Number:15/446,933
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the key aspects of patent scope and claims, using the example of US Patent 11,324,741, and provide a comprehensive overview of the patent landscape in the United States.

What is a Patent?

A patent is a form of intellectual property that grants the owner the exclusive right to make, use, sell, and distribute an invention for a specified period, typically 20 years from the filing date. Patents are essential for protecting innovations and encouraging investment in research and development[4].

The Importance of Claim Scope

The claim scope in a patent application is critical because it defines the boundaries of the invention and determines the extent of the protection granted. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate[3].

Factors Influencing Claim Scope

Several factors influence the determination of the right claim scope:

  • The Actual Invention: The claims must be anchored to the embodiments described in the specification.
  • Prior Art: In fields with extensive prior art, broader claims are harder to get allowed.
  • Client’s Budget: The cost of getting a patent granted on broader claims can be higher.
  • Technical Field: The level of innovation and the existing patent landscape in the technical field[3].

Drafting Patent Claims

When drafting claims, it is important to avoid overly broad language that could lead to invalidation. Here are some key considerations:

Abstract Idea Exception

The abstract idea exception, often referred to as the Alice exception, is a significant risk for overly broad claims. This exception prevents patents from granting a monopoly over abstract ideas by ensuring that the claims are directed to a specific means or method that improves the relevant technology[3].

Written Description Requirement

Claims must also meet the written description requirement, meaning they must be supported by the specification. If the claims go beyond what is described, they risk being invalidated[3].

Case Studies: Understanding Claim Scope Through Court Decisions

Yu v. Apple Inc.

In the case of Yu v. Apple Inc., the Federal Circuit court invalidated a claim because it was directed to a result or effect that was an abstract idea, rather than a specific means or method. This highlights the importance of ensuring that claims are specific and tied to the embodiments described in the specification[3].

Minerva Surgical, Inc. v. Hologic, Inc.

The Minerva Surgical, Inc. v. Hologic, Inc. case, while primarily about assignor estoppel, also illustrates the risks of claim broadening. The file history of the patents involved shows how broadening claims can lead to invalidation issues[3].

Valuation of Patents

Understanding the value of a patent is crucial for businesses and inventors. Here are some key points on patent valuation:

Valuation Methods

There are three primary methods for valuing patents: cost, income, and market.

  • Cost Approach: This method considers the cost of developing the patent.
  • Income Approach: This method looks at the future benefits provided by the patent.
  • Market Approach: This method determines value based on what a willing buyer would pay for a similar asset[1].

Recent Transactions

Recent transactions provide insight into patent values. For example, in 2011, Rockstar Bidco paid $4.5 billion for 6,000 patent documents from Nortel, averaging $750,000 per patent document. Google's acquisition of Motorola Mobility for $12.5 billion included 24,500 patents and applications, highlighting the significant value placed on patent portfolios[1].

Patent Landscape in the United States

The patent landscape in the U.S. is dynamic and influenced by various factors:

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. The Administrative Conference of the United States (ACUS) has conducted extensive research and gathered public comments on this topic[2].

Global Dossier and International Harmonization

The USPTO's Global Dossier service aims to modernize the global patent system by providing a single portal for accessing file histories of related applications from participating IP offices. This service facilitates international patent searches and harmonization[4].

Public Search Facilities and Resources

The USPTO offers various resources for patent searches, including the Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and the Electronic Official Gazette. These resources help inventors and businesses navigate the patent landscape effectively[4].

Example: US Patent 11,324,741

To illustrate the concepts discussed, let's consider a hypothetical analysis of US Patent 11,324,741 (note: this patent is not specified in the sources, so this section will be general).

Claim Analysis

  • Claim Scope: The claims of US Patent 11,324,741 would need to be carefully reviewed to ensure they are specific, supported by the specification, and do not fall under the abstract idea exception.
  • Prior Art: A thorough search of prior art would be necessary to ensure that the claims are novel and non-obvious.

Valuation

  • Income Approach: The future benefits provided by this patent, such as licensing fees or cost savings, would be calculated to determine its income value.
  • Market Approach: Comparisons with similar patents in the same field would help determine the market value.

Key Takeaways

  • Claim Scope is Critical: The scope of claims in a patent application must be carefully defined to ensure validity and enforceability.
  • Valuation Methods: Patents can be valued using cost, income, and market approaches.
  • Dynamic Patent Landscape: The U.S. patent landscape is influenced by ongoing legal and policy changes, including discussions on small claims patent courts and international harmonization.
  • Resources Available: The USPTO and other organizations provide extensive resources for patent searches and analysis.

FAQs

What is the primary purpose of a patent?

A patent grants the owner the exclusive right to make, use, sell, and distribute an invention for a specified period, typically 20 years from the filing date.

Why is claim scope important in a patent application?

Claim scope defines the boundaries of the invention and determines the extent of the protection granted. It must be specific, supported by the specification, and avoid being overly broad to prevent invalidation.

What are the three main methods for valuing patents?

The three main methods are the cost approach, income approach, and market approach. Each method considers different aspects of the patent's value, such as development costs, future benefits, and market comparisons.

What is the Global Dossier service provided by the USPTO?

The Global Dossier service is a set of business services aimed at modernizing the global patent system by providing a single portal for accessing file histories of related applications from participating IP offices.

Why is there a need for a small claims patent court?

The need for a small claims patent court arises from the high costs and complexities associated with patent litigation. Such a court could provide a more accessible and cost-effective way to resolve patent disputes.

Sources

  1. The Value of a Patent - Perpetual Motion Patents
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States
  3. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law
  4. Search for Patents - United States Patent and Trademark Office

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,324,741

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Nalpropion CONTRAVE bupropion hydrochloride; naltrexone hydrochloride TABLET, EXTENDED RELEASE;ORAL 200063-001 Sep 10, 2014 RX Yes Yes 11,324,741 ⤷  Try for Free FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,324,741

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2725930 ⤷  Try for Free
European Patent Office 2303025 ⤷  Try for Free
Japan 2011521973 ⤷  Try for Free
Japan 2014148554 ⤷  Try for Free
Mexico 2010012909 ⤷  Try for Free
World Intellectual Property Organization (WIPO) 2009158114 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.